WHO Warns: Ebola Outbreak in DR Congo Started Earlier Than Reported

According to the World Health Organization (WHO), the latest Ebola outbreak in the Democratic Republic of Congo (DRC) began at least three months before its official declaration on May 15, leaving health authorities playing catch-up as infections remain high and over 1,900 people have died.

How the DRC Ebola Outbreak Went Undetected for Months

The latest resurgence of the virus in the DRC has already claimed 1,960 lives out of 4,294 confirmed cases, according to figures released by the DR Congo health ministry and reported by infohub.kz. This makes it the second-worst Ebola outbreak in history, sitting behind only the massive West African epidemic between 2014 and 2016 that killed 11,325 people. Yet, the crisis reached this staggering scale largely because the pathogen was circulating undetected for a quarter of a year.

Research cited by health officials reveals that the epidemic actually ignited in February. During those initial hidden weeks, medical workers frequently misdiagnosed the symptoms as malaria or typhoid. Because authorities did not officially recognize the threat until May 15, the virus established a deep foothold before containment protocols ever rolled out.

Dr. Mohamed Janabi, the WHO Africa director, acknowledged the grim reality during a press briefing in the city of Bunia, which sits squarely at the center of the zone. “We are chasing the virus, the virus is ahead of us,” Dr. Janabi stated, according to the WHO and infohub.kz.

Why Eastern DR Congo’s Geography and Security Crisis Fuel the Virus

Containing the current emergency poses distinct hurdles compared to past epidemics due to the specific strain involved and the volatility of the region. The epicentre sits firmly in the east of the DRC, where ongoing insecurity severely hampers deployment, surveillance, and clinical interventions.

Compounding the geopolitical instability is the nature of the pathogen itself. This outbreak involves the Bundibugyo species of Ebola. Unlike other strains, health systems face a stark therapeutic void against this variant: there is no approved vaccine or any recognized therapeutic drugs available to treat the Bundibugyo species, making clinical management considerably more difficult.

On-the-ground operations face daily friction from community dynamics as well. According to the WHO and infohub.kz coverage, health workers are only managing to reach roughly 30% of active cases, leaving the remaining 70% of patients to pass away inside their homes. This dangerous gap is exacerbated by traditional burial practices—where grieving mourners routinely touch the deceased’s body—alongside a lingering suspicion of health authorities among certain local populations.

Treatment Infrastructure and Current Diagnostics Speed

Despite the severe obstacles posed by local insecurity and the lack of targeted pharmaceuticals, health authorities are scaling up localized infrastructure. Several dedicated treatment centres are now operational across the eastern region of the DRC, allowing medical teams to diagnose incoming patients much more quickly than during the initial hidden weeks.

While infection rates remain stubbornly high, these specialized facilities represent a vital anchor for communities trying to turn the tide against the Bundibugyo species. As medical personnel work to build trust and expand their reach beyond that initial 30% threshold, the broader public health apparatus continues racing to catch up to a virus that got a three-month head start.